Free Trial
NYSE:JATT

JATT Acquisition (JATT) Stock Price, News & Analysis

JATT Acquisition logo
$2.88 +0.08 (+2.86%)
(As of 12/6/2024 ET)

About JATT Acquisition Stock (NYSE:JATT)

Key Stats

Today's Range
$2.76
$2.96
50-Day Range
$2.70
$8.16
52-Week Range
$7.80
$12.38
Volume
806,057 shs
Average Volume
41,322 shs
Market Capitalization
$49.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

JATT Acquisition Corp does not have significant operations. It intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on businesses primarily operating in the life sciences sector. JATT Acquisition Corp was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

Receive JATT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JATT Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JATT Stock News Headlines

Radical change could be coming — do this NOW to protect yourself
Legendary financial forecaster, Dr. Martin Weiss has recently uncovered what could be the Deep State's chilling plan to radically change America forever. It involves the Fed … Artificial Intelligence … And a Draconian set of laws that could install total financial surveillance …
See More Headlines

JATT Stock Analysis - Frequently Asked Questions

JATT Acquisition's stock was trading at $8.16 at the beginning of 2024. Since then, JATT shares have decreased by 64.7% and is now trading at $2.88.
View the best growth stocks for 2024 here
.

Shares of JATT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
12/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$6.85 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.11 per share
Book Value
($0.53) per share

Miscellaneous

Free Float
13,800,000
Market Cap
$49.68 million
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSE:JATT) was last updated on 12/8/2024 by MarketBeat.com Staff
From Our Partners